Related Experiment Video
Updated: Jul 16, 2026

08:34
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 15, 2012
A value analysis model applied to the management of amblyopia
G R Beauchamp1, M C Bane, D R Stager
1Center for Adult Strabismus, Dallas, Texas, USA.
Transactions of the American Ophthalmological Society
|March 7, 2000
Summary
The health value model (HVM) shows amblyopia care is valuable but undercompensated. Patients value services more than physicians, highlighting financial concerns in pediatric eye care.
Area of Science:
- Ophthalmology
- Health Services Research
- Pediatric Care
Background:
- Amblyopia, or
- lazy eye
- is a common cause of visual impairment in children.
- Effective management requires early detection and sustained patient compliance.
- Assessing the value of amblyopia services is crucial for optimizing care delivery.
Purpose of the Study:
- To evaluate the value of amblyopia services using a health value model (HVM).
- To assess cost and quality criteria from patient, physician, and purchaser perspectives.
- To determine if current compensation reflects the true value of amblyopia care.
Main Methods:
- Application of an HVM to a hypothetical child with amblyopia (visual acuity 20/80) and a cohort of treated children.
- Evaluation of patient and physician responses regarding service quality and outcomes.
- Correlation of subjective value appraisals with objective clinical results.
Main Results:
- The HVM calculated a consensus value of 0.406 for the hypothetical child and 0.682 for the practice cohort.
- Clinical outcomes showed 79% achieved 20/40 or better vision, with a mean final acuity of 20/32.
- Physicians expressed significant financial concerns, while patients reported more positive service experiences.
Conclusions:
- Amblyopia care is demanding but vital, necessitating strong patient and family support.
- Patient-reported value significantly exceeds physician-reported value, indicating a disconnect.
- Amblyopia services are undercompensated relative to their high value and the costs of treatment failure.

